The Paris Bourse is affirmed in the rise
Posted by adminThe Paris Bourse is in the green: After opening up shy of 0.3% to 3567.99 points, the CAC 40 is accelerating its progress towards 9.30, with an increase of 0.67% to 3581.17 points. After Thursday's rebound, which has won 40 of auCAC 1.59%, investors want to continue in the green, ignoring the pause in Asian markets this morning, one that has also been chosen by U.S. operators yesterday. The Dow Jones, which had won 2.25% Wednesday, finished the balance 0.06% Thursday.
The wait should also dominate this session before the release of highly anticipated monthly report on U.S. employment, which will be published early this afternoon. Yesterday, the markets have had a foretaste of what awaited the publication of a fall, slightly above expectations ds, the weekly number of new unemployed (453,000).The firm ADP, meanwhile, announced that the private sector was announced in May its fourth consecutive month of net job creation (55 000). Despite these figures, the head of the U.S. Federal Reserve (Fed), Ben Bernanke, said he still worried about the employment situation overseas. An hour after the publication of the report, the Fed chairman Atlanta, Dennis Lockhart will speak on the economic outlook and the banking environment.
Note that the second estimate of euro area GDP in the first quarter will be unveiled in the morning.
Rumors about Valeo title propels upward
Valeo recorded the largest increase in the Parisian market, gaining 6.93%.The automotive supplier would consider a delisting, the sale of a business or a merger with U.S. rival, says the New York Times this morning, noting that Bank of America – Merrill Lynch has been appointed to investigate these scenarios.
In an interview with Les Echos published Thursday, Industry Minister Christian Estrosi, spoke in favor of a rapprochement between the players of the electronics and embedded software as those of Thales. The title ahead of 0.69%.
CGG Veritas allows itself 1.49% after the Strategic Investment Fund (ISF) is mounted in its capital to the tune of just over 170 million euros, or 6% of capital. Other oil stocks also posted good gains. Thus, Total (1.59%), Technip (1.73%) and Vallourec (1.54%) appear among the highest increases in the Cac 40.
Leading the index are this morning Alcatel-Lucent (2.34%) and ST Microelectronics (2.06%).Both tracks benefit from a higher perspective of microprocessor sales by Gartner.
France Telecom (1.53%) announced Thursday it had abandoned its proposed merger with its Swiss subsidiary Sunrise, a subsidiary of TDC, but did not specify its intentions for other building projects in the country.
Airbus is Boeing's double
Airbus, a subsidiary of EADS (0.61%), registered 73 net orders from January to May, but still lagging behind U.S. rival Boeing, which has registered 111, according to the trade balance of the two aircraft manufacturers.
BPCE, parent company of Natixis (1.27%), formalizing the merger Thursday holdings of shares of Banques Populaires and Caisses d'Epargne.
BNP Paribas (0.39%), which Fortis bought at the height of the financial crisis, announced Thursday an agreement in principle to merge its Turkish subsidiary with that of the Belgian bank.
Axa gained 0.72%.National Australia Bank has found three candidates may be interested in acquiring a platform investment Axa Asia-Pacific by Australian newspaper on Friday.
Atos Origin (+0.88%) have submitted a bid for the resumption of WorldPay, a subsidiary of Royal Bank of Scotland, according to sources familiar with the matter.
Saint-Gobain (0.39%) has a bearing on the title of recommendation by HSBC, which goes from "underweighted" to "neutral." Jean-Louis Beffa, the chairman of Saint Gobain, has formalized his departure at the annual general meeting Thursday.His successor, Pierre-Andre de Chalendar confirmed its objective of a rebound results in 2010 and said to expect solid growth in operating income in the first half, compared to the same period last year.
Air France-KLM (0.71%) is considering an annual loss of 300 million euros this year, burdened by the cost of its fuel hedges, reported The Tribune.
Sanofi-Aventis (+0.32%) has signed an exclusive worldwide agreement in the treatment of cancer with U.S. biotech company Ascenta, the company said Friday.